Next Article in Journal
Dim Flicker: An Endogenous Visual Percept and Its Disease Associations
Previous Article in Journal
Learning Curve of Cardiac Surgery Residents in Transit-Time Flow Measurement and High-Resolution Epicardial Ultrasonography During Coronary Surgery
Previous Article in Special Issue
Effects of Task-Oriented Training on Gait Outcomes and Balance in Individuals with Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effects of Gamified Virtual Reality on Muscle Strength and Physical Function in the Oldest Old—A Pilot Study on Sarcopenia-Related Functional Outcomes

by
Żaneta Grzywacz
1,*,
Justyna Jaśniewicz
1,
Anna Koziarska
2,
Joanna Macierzyńska
3 and
Edyta Majorczyk
3,*
1
Faculty of Production Engineering and Logistics, Opole University of Technology, 76 Prószkowska St., 45-758 Opole, Poland
2
Center of Education Applications of Mathematic, Opole University of Technology, 76 Prószkowska St., 45-758 Opole, Poland
3
Faculty of Physical Education and Physiotherapy, Opole University of Technology, 76 Prószkowska St., 45-758 Opole, Poland
*
Authors to whom correspondence should be addressed.
J. Clin. Med. 2026, 15(2), 621; https://doi.org/10.3390/jcm15020621
Submission received: 24 November 2025 / Revised: 5 January 2026 / Accepted: 6 January 2026 / Published: 13 January 2026

Abstract

Background/Objectives: Sarcopenia is an age-related decline in muscle mass and strength, reducing mobility and functional independence and increasing the risk of falls. Non-pharmacological interventions remain the most effective strategies to prevent or delay its progression, with exercise recognized as the primary approach. Virtual reality (VR)-based training has recently emerged as a promising tool to promote physical activity; however, its application among the oldest-old individuals remains underexplored. This is a randomized controlled pilot study to evaluate the effects of VR-based intervention using the game “Beat Saber” on muscle strength and selected physical performance indicators related to sarcopenia risk in older adults. Methods: Thirty-eight residents (mean age: 87.2) of a long-term care facility were randomly assigned to either a VR group or a control group. The VR group participated in 12 supervised VR-based training sessions of 20 min per session, three times per week for four weeks. Handgrip strength, the arm curl test, 30-s chair stand, a 2-min step-in-place test, and an 8-foot up-and-go test were assessed before and after the intervention. Results: Linear mixed-model analyses revealed significant group-by-time interactions for upper- and lower-limb strength (handgrip, arm curl, chair stand; p < 0.05), favoring the VR group. Agility and endurance (8-foot up-and-go, 2-min step-in-place) showed no significant interactions. In the VR group, the 30-s chair stand performance correlated positively with the arm curl and the 2-min step-in-place tests results, while handgrip strength correlated with the arm curl performance. In the control group, the 30-s chair stand test results correlated strongly with the 8-foot up-and-go and 2-min step-in-place tests, but no significant correlations were found for handgrip strength. Conclusions: The findings indicate short-term functional benefits of VR exercise among the oldest-old adults. VR-based training appears to be an effective and well-tolerated method to enhance physical performance in individuals aged 80 and older and may represent a valuable strategy for improving functional performance indicators associated with sarcopenia risk in adults aged 80 years and older.

1. Introduction

With the progressive aging of populations worldwide and the increasing prevalence of geriatric syndromes, greater attention is being given to the health challenges faced by the elderly, including the need for care, support and medical intervention. Thus, within aging populations, an increasing proportion of individuals aged 80 years and older, commonly defined as the oldest-old, present with substantial functional limitations and heightened vulnerability.
Among the conditions associated with aging sarcopenia stands out as a particularly common and serious issue, representing a significant public health challenge [1]. Officially recognized as a disease in 2016, sarcopenia is a syndrome characterized by the gradual loss of muscle mass and strength, which leads to reduced mobility, a higher risk of falls and a loss of functional independence [2,3]. As key aspects of sarcopenia, such as muscle quantity and quality, remain challenging to assess accurately in clinical practice, the diagnosis is typically based on multiple parameters. According to the revised guidelines of the European Working Group on Sarcopenia in Older People (EWGSOP2), the diagnostic process involves the assessment of muscle strength (e.g., handgrip strength or chair stand test), confirmation by evaluating muscle mass or quality, and, when applicable, the evaluation of physical performance. Moreover, EWGSOP2 recommends calf circumference (CC) and mid-upper-arm circumference (MUAC) as practical screening tools. The use of clearly defined cut-off points for each variable allows for the identification and staging of sarcopenia [4]. For example, the CC of ≤31 cm is commonly used as a threshold for sarcopenia. In the case of MUAC, values <22 cm for women and <23 cm for men are indicative of potential muscle mass loss.
Elderly people are particularly at risk of sarcopenia, as their natural ability to regenerate and adapt physically is limited [1,5,6,7]. Sarcopenia is estimated to affect 5% to 13% of individuals over the age of 60, with prevalence increasing to 50% among those aged 80 and older [8]. The main risk factors for development of sarcopenia include a lack of regular physical activity, chronic inflammation, metabolic diseases and nutritional deficiencies, particularly inadequate intake of protein and vitamin D [4,9,10].
Currently, no effective pharmacological treatments are available for sarcopenia, and non-pharmacological interventions remain the most appropriate and effective strategies to prevent or delay its progression [11], with exercise recognized as the primary intervention. The key challenge, therefore, lies in motivating older adults to engage in physical activity. In response to this issue, games in virtual reality (VR), particularly those that incorporate motor and cognitive components, offer a promising avenue for supporting older adults [12]. Supervised exercise programs incorporating gamification have been shown to increase physical activity levels in individuals with chronic conditions when compared to standard exercise. This approach may enhance engagement in physical activity, provided that appropriate supervision is ensured. However, further high-quality studies and subgroup analyses are needed to fully evaluate the long-term impact of gamified interventions in patients with chronic diseases [13].
Unfortunately, older adults are among the populations most affected by digital exclusion, due not only to technical infrastructure limitations, but more importantly to negative beliefs and stereotypes that perpetuate this exclusion [14]. Games are often perceived as the domain of younger individuals and may be considered unattractive or irrelevant to the elderly. Nonetheless, emerging evidence suggests that the use of VR-based technologies can positively influence the physical, cognitive, and mental health of the elderly [15,16]. Despite increasing interest in VR-based rehabilitation for older adults, high-quality evidence remains scarce, particularly for the oldest-old (≥80 years). Most studies focus on younger seniors (60–75 years), limiting the applicability of findings to older age groups [17,18]. Existing evidence suggests that VR may improve balance and gait but not lower limb strength [17], and that VR-based training can benefit activities of daily living, frailty, and mental health [18]. However, most interventions do not use widely available commercial games. While titles such as Beat Saber show promise in younger adults [19], no randomized controlled trials have examined their effects in those ≥80 years. Consequently, the effectiveness of VR in both preventing and treating sarcopenia among the oldest-old remains uncertain, and robust evidence on its long-term impact is lacking.
Therefore, this study was designed as a randomized controlled pilot trial to evaluate the effects of a rhythm-based virtual reality intervention on physical performance parameters related to sarcopenia risk in the oldest-old population (≥80 years). The primary hypothesis was that short-term VR-based training would result in greater improvements in upper-limb muscle strength compared with standard institutional physical activity. The primary outcome was handgrip strength. Secondary outcomes included the arm curl test, lower-limb functional performance, aerobic endurance, agility, and dynamic balance.

2. Materials and Methods

2.1. Participants

This study is a secondary analysis using data from a previously conducted randomized controlled trial described by Grzywacz et al. (2025) [20]. The primary aim of the original study was to assess the effects of virtual-reality-based gaming on visuomotor coordination and attention in the oldest-old population. The present secondary analysis was pre-planned to examine a different set of outcomes derived from the same intervention and cohort, specifically functional performance indicators related to sarcopenia risk.
The cohort consisted of 38 long-term residents of a nursing home in Opole (29 women and 9 men), all aged 65 or older, who were randomized by sex into two groups (VR group and control group) in a 1:1 ratio using the Research Randomizer tool (https://www.randomizer.org/, accessed on 19 July 2024), with stratification by sex to ensure balanced distribution of women and men between groups. The randomization sequence was generated prior to group allocation, and assignment was performed after participant enrollment.
Participants were exposed to comparable daily routine activity schedules and meal provision, as physical activity and dietary plans were institutionally standardized for all residents and monitored by facility staff. Daily activity levels and dietary intake were not quantitatively assessed using questionnaires, dietary records or wearable devices. Therefore, these factors were controlled at the organizational level rather than measured directly. All participants continued participation in the facility’s standard physical activity program, which focused on maintaining general mobility and motor coordination. Participants in the VR group also engaged in virtual-reality-based gaming, as detailed in the Intervention section.
Anthropometric parameters relevant to the assessment of sarcopenia were assessed using standardized procedures, as described below. Calf circumference was measured at the widest part of the dominant calf without compressing the skin or underlying muscle. Participants were seated comfortably with knees flexed at 90 degrees and feet flat on the floor. Mid-upper-arm circumference was measured on the non-dominant arm at the midpoint between the acromion and olecranon processes. Participants remained seated with the arm relaxed alongside the body. All measurements were performed using a non-stretchable tape, and two readings were taken for each site and averaged if the difference between them was ≤0.5 cm. Final values were recorded to the nearest 0.1 cm.
The study protocol was approved by the Bioethics Committee of the Hirszfeld Institute of Immunology and Experimental Therapy (approval number: KB-10/2024), and conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. All participants signed an informed consent form prior to enrolment.
This pilot study was retrospectively registered (ClinicalTrials.gov Identifier: NCT06864325). The registration occurred after data collection due to the exploratory, feasibility-oriented nature of the project.
Additionally, seniors were qualified to this study through physician assessment of general health and screening for contraindications to VR headset use. Eligibility criteria required participants to be 60 years of age or older, in generally good physical condition, and willing to provide written informed consent for participation. Individuals were excluded if consent was not granted or if contraindications to the use of a VR headset were present. These included temporary conditions such as fatigue or exhaustion, drowsiness, nausea, anxiety or stress, as well as acute illnesses (e.g., cold or flu), and chronic conditions, including active cancer undergoing intensive treatment, inability to perform physical exercise, visual or hearing impairments preventing the use of VR goggles, or cognitive disorders that limited comprehension of exercise instructions or cooperation with the research team.

2.2. Study Design—Intervention

This study followed the CONSORT 2010 guidelines, with participant enrollment and allocation shown in Figure 1. The VR intervention protocol was identical to that described in our previous publication [20]. For this secondary analysis, the same study design was used. Briefly, participants randomly allocated to the VR group completed a 4-week virtual reality exercise program using the commercial rhythm game Beat Saber, delivered via a Meta Quest 2 head-mounted display (Meta Platforms, Inc., Menlo Park, CA, USA). Beat Saber is a commercial virtual reality game developed by Beat Games and distributed by Meta Platforms, Inc., and was used under standard consumer conditions without any modification in software or content. The system used integrated inside-out 6DoF tracking, and participants held two motion controllers, each weighing approximately 150 g. Training was performed in a seated position within a safe 1.5 m × 1.5 m area. The game was set at the “Easy” difficulty level for all participants, with the “No Arrows” and “No Walls” modifiers activated to reduce cognitive and balance demands. The difficulty level remained constant throughout the intervention, as the primary aim was safety and feasibility assessment rather than progressive overload. Sessions lasted approximately 20 min and were conducted three times per week. The program emphasized upper-limb movements synchronized with audiovisual stimuli and was supervised by a physiotherapist to ensure safety and appropriate adaptation to each participant’s functional capacity. Participants assigned to the control group continued their routine physical activity program provided by the institution. The program aimed to maintain general physical function and coordination and was tailored to the functional capacities of older residents. Sessions typically consisted of preparatory movements, light whole-body exercises using basic equipment (e.g., elastic bands, sticks, or light hand weights), followed by simple coordination tasks such as rhythm-based movements or ball exercises, and concluded with stretching and relaxation components. All sessions were supervised by a physiotherapist and incorporated elements supporting social interaction. The control group intervention did not include virtual reality exposure or gamified elements and represented routine care provided by the institution. Both the VR and control interventions were delivered over the same 4-week period, with comparable session frequency and duration, and were supervised by a physiotherapist to ensure participant safety.
A visual representation of the training setup and game interface is provided in Figure 2.

2.3. Outcomes Measures

All assessments were conducted at two time points: baseline (T0) and after the completion of the 4-week intervention period (T1; approximately 20 min after the last session). The measurements focused on parameters related to sarcopenia risk, such as an upper-limb strength and physical performance.

2.3.1. Muscle Strength (Handgrip Strength)

Muscle strength was assessed using the MG-4800 digital medical hand dynamometer (Shenzhen Camry Electronic Co., Ltd., Shenzhen, China) to measure isometric handgrip force. The device, equipped with a 20 kg resistance spring, provided reliable and accurate measurements within the strength range of older adults. Participants were seated on an armless, straight-backed chair with feet flat on the floor. The test was performed on the dominant hand with the elbow flexed at 90°, forearm in a neutral position (thumb up), and wrist in slight extension, following standardized handgrip testing procedures. The dynamometer grip was adjusted to match the participant’s hand size for optimal positioning and ergonomics. Participants were instructed to squeeze the handle with maximum effort for 3–5 s while avoiding trunk or shoulder compensation. At both time points (T0 and T1), three trials were performed with at least 30 s of rest between attempts. The final score was calculated as the average of the three trials. Although the Jamar dynamometer is commonly considered the gold standard for handgrip strength assessment, the same device was used consistently across all participants and time points. Therefore, the handgrip strength results were interpreted primarily in terms of within-group and between-group changes rather than absolute normative comparisons.

2.3.2. Functional Fitness Battery

Physical performance was assessed using four tests from the Senior Fitness Test (SFT) protocol: the 30-s chair stand test (lower body strength), the arm curl test (upper-limb muscular endurance; 2 kg dumbbell for women, 3 kg for men), the 2-min step-in-place test (aerobic capacity; number of right-leg steps recorded), and the 8-foot up-and-go test (agility and dynamic balance). These measures were selected as potential indicators of sarcopenia. Detailed testing procedures followed the standardized methodology as described previously [21]. All assessments were conducted by trained staff under standardized conditions and repeated at baseline (T0) and post-intervention (T1) to evaluate functional changes.

2.3.3. Statistical Analyses

Demographic and anthropometric characteristics of the participants, including age, height, weight, and BMI, were analyzed using descriptive statistics. The Shapiro–Wilk test was applied to assess the normality of data distribution. To assess the effects of the intervention, linear mixed models (LMMs) were applied with time (T0 and T1), group (VR group, control group), and their interaction (time × group) as fixed factors, and participants (ID) as a random intercept. This approach accounted for the repeated-measures structure of the data and individual variability. The significance of fixed effects was tested using the Satterthwaite test with Type III sums of squares. Estimated marginal means and 95% confidence intervals were reported for each condition. To assess the strength and direction of associations between measured outcomes, Spearman’s rank correlation coefficient (rho) was calculated. This non-parametric method was used due to non-normal distributions of the certain analyzed data. p-values ≤ 0.05 were considered statistically significant. Statistical analyses were performed using Statistica v.13 (StatSoft, Inc., Tulsa, OK, USA) and the JAMOVI statistical software (version 2.6.26) for specific paired comparisons and effect size calculations. No a priori sample size calculation was performed, as this study was designed as a pilot and feasibility-oriented investigation.

3. Results

For anthropometric characteristics of the study groups, as well as recorded baseline anthropometric parameters relevant to the assessment of sarcopenia (calf and mid-upper-arm circumferences, see Table 1.
The presented results were collected from participants in accordance with the CONSORT flow Grzywacz et al., 2025 [20]. No dropouts, adverse events, or intervention-related complications were observed in either group during the study period. The measures related to sarcopenia risk were chosen among widely used indicators: a handgrip strength test and functional fitness battery tests such as arm curl, 30-s chair stand, 8-foot up-and-go, and 2-min step-in-place. All parameters were assessed at two time points: prior to the intervention (T0) and following the intervention (T1). All participants were divided into two groups: the VR group (n = 19) and the control group (n = 19). For certain analyzed data, non-normality of distributions were observed; thus, central tendency is reported using both median with Q1–Q3 quartiles range and mean with standard deviation (Table 2). Muscle-mass-related anthropometric parameters were assessed at baseline and post-intervention; however, no statistically significant changes were observed. Due to the short duration of the intervention, the outcomes were interpreted primarily as functional performance indicators associated with sarcopenia risk rather than as evidence of structural muscle adaptations or sarcopenia diagnosis.
These thresholds were derived from validated criteria reported in previous studies and international guidelines (EWGSOP2, 2019, [4]; Lima et al., 2023 [22]; Sawada et al., 2021 [23]; Martinez et al., 2015 [24]; Poncumhak et al., 2023) [25] and indicate functional performance levels associated with an increased risk of sarcopenia rather than a con-firmed clinical diagnosis. The cut-off points used to classify participants as being at risk of sarcopenia, together with the corresponding references, are presented in Table A1 (Appendix A).
Linear mixed-model analyses were performed to examine the effects of the VR-based intervention on muscle strength and physical performance over time (Table 2). For handgrip strength, the main effects of time (F = 0.10, p = 0.754) and group (F1 = 0.22, p = 0.643) were not significant; however, the time × group interaction reached significance (F = 4.68, p = 0.037). Estimated marginal means indicated that handgrip strength showed a small increase in the VR group (17.93 kg at T0 and 18.69 kg at T1), while it declined slightly in controls (17.82 and 17.25 kg, respectively at T0 and T1), suggesting a small protective effect of the VR intervention. For the arm curl test, significant main effects of time (F = 10.16, p = 0.003) and group (F = 18.70, p < 0.001) were observed, together with a significant time × group interaction (F = 6.57, p = 0.015). The VR group improved markedly (14.16 to 18.53 repetitions), whereas the control group showed only a minimal change (T0: 10.32 and T1: 10.79). In the 30-s chair-stand test, all effects were significant: time (F = 21.21, p < 0.001), group (F = 23.64, p < 0.001), and time × group (F = 22.67, p < 0.001). Performance in the VR group increased substantially (9.32 to 12.47 repetitions), while no meaningful change occurred in the controls (4.16 and 4.11, respectively at T0 and T1). For the 8-foot up-and-go test, neither the main effects nor the interaction were significant (time, p = 0.165; group, p = 0.657; time × group, p = 0.301), indicating comparable agility performance across groups. Finally, for the 2-min step-in-place test, significant main effects of time (F = 6.84, p = 0.013) and group (F = 7.43, p = 0.010) were found, but the interaction was non-significant (p = 0.990). Both groups improved slightly over time, though the VR group maintained higher overall step counts (T0: 74.7 and T1: 85.8 steps) compared to controls (42.2 to 53.2 steps).
Overall, the mixed-model results demonstrate significant group-by-time interactions for upper- and lower-limb strength (handgrip, arm curl, chair stand), supporting the effectiveness of the VR intervention in enhancing functional performance among the oldest-old participants.
Moreover, Spearman’s correlations coefficients were calculated to illustrate the relationships between all variables indicative of sarcopenia risk. In Figure 3, squares outlined in red indicate statistically significant correlations between different parameters (p < 0.05), with their strength and direction of the associations represented by color saturation (warm hues indicating positive correlations and blue hues indicating negative correlations). To facilitate the analysis, statistically significant relationships for the same parameters measured at two time points (T0 and T1) were not marked in the figure. In the VR group, the 30-s chair stand test showed moderate to strong positive correlations with both the arm curl and the 2-min step-in-place tests results, measured before and after intervention. Specifically, the 30-s chair stand at T0 correlated positively with the arm curl tests at both T0 and T1, as well as with the 2-min step-in-place test at T0. Similarly, the 30-s chair stand at T1 correlated positively with both the arm curl and the 2-min step-in-place tests at T0 and T1. Additionally, handgrip strength at T0 correlated negatively with both T0 and T1 results of the 2-min step-in-place tests, whereas handgrip strength at T1 showed a positive correlation with the arm curl test at the same time point. In the control group, several significant positive correlations were observed among some physical performance measures, primarily at the time point before the intervention. The 30-s chair stand test at both T0 and T1 showed strong positive correlations with the 8-foot up-and-go at T0 and T1, as well as with the 2-min step-in-place test at T0 and T1. Furthermore, the 8-foot up-and-go at T0 and T1 and the 2-min step-in-place test at T0 and T1 positively correlated among themselves. In contrast to the VR group, no significant correlations were observed between handgrip strength and other parameters in the control group.

4. Discussion

The aim of this pilot study was to evaluate the potential of the commercial VR game Beat Saber to improve functional performance indicators associated with sarcopenia risk in the oldest-old population. The results indicate that a 4-week virtual-reality-based training can significantly improve selected physical fitness parameters related to sarcopenia risk in elderly individuals. The most notable improvements were observed in upper limb strength (arm curl test) and lower limb endurance (30-s chair stand test). In the VR group, handgrip strength remained stable over the course of intervention, whereas a decline was observed in the control group. Moreover, our findings suggest that, within the VR group, baseline muscle strength and physical performance were interrelated and improvements in handgrip strength corresponded with better functional outcomes following the intervention. In contrast, the control group exhibited fewer dynamic changes across the same measures, suggesting that standard physical activity alone may be less effective in enhancing short-term functional fitness in this population. It should be noted that the modest decline observed in handgrip strength in the control group likely reflects short-term biological and measurement variability commonly reported in very old adults, rather than a true or clinically meaningful deterioration in muscle function over such a brief period [26].
Overall, both the VR and control groups showed a reduced frequency of sarcopenia indicators based on established score cut-off points; however, the reduction was more pronounced in the VR group. In particular, we employed the widely recognized handgrip strength test, which is considered a strong predictor of overall health and mortality in older adults [27]. The test results remained stable in the VR group but declined in the control group, suggesting a potential protective effect of VR-based training. Our intervention shared some characteristics with low-intensity, resistance-like upper-limb activity through the use of the Beat Saber game, in which the mass of the controllers and rapid, rhythmic arm movements likely provided dynamic resistance. Even low-intensity resistance-type activity, when delivered in an engaging format, can yield measurable functional benefits. Previous research shows that moderate, resistance-based exercise performed regularly can improve grip strength and physical function [28,29,30] but has limited effects on muscle mass [31]. In contrast, traditional resistance and multicomponent exercise programs, considered the cornerstone of sarcopenia management, typically rely on structured protocols and progressive overload and have demonstrated robust improvements in muscle strength and functional performance in older adults [32]. In contrast, the present VR-based intervention was not designed to elicit comparable physiological training responses but rather to examine short-term functional feasibility in the oldest-old population. It is possible that our VR-based intervention primarily induced early neuromuscular adaptations such as improved motor unit recruitment and efficiency before measurable hypertrophy occurred, consistent with the phenomenon described by Song et al. (2023) [33]. Moreover, for assessment of measures related to sarcopenia risk, we employed a battery of functional fitness tests, consisting of several simple but effective measures that provide a broad evaluation of physical performance, including lower body strength, upper-limb muscular endurance, aerobic capacity, agility and dynamic balance Accordingly, improvements in selected functional outcomes related to endurance and dynamic task performance (2-min step-in-place, 8-foot up-and-go) observed in the VR group suggest potential benefits in movement coordination and task execution. However, no consistent improvements were observed in agility-specific measures. This finding is consistent with previous studies indicating that improvements in agility and rapid directional changes typically require task-specific, weight-bearing, and progressively challenging training stimuli, particularly in very old populations [34,35].
In this paper, a comprehensive evaluation consists of correlations between analyzed components of physical fitness, which are often interrelated [36,37]. Our model revealed, in the VR group, consistent moderate-to-strong correlations between lower-body strength, upper-limb endurance, and aerobic capacity both before and after the intervention. In contrast, the control group showed significant associations between functional measures, which were observed mainly at baseline, with no notable correlations involving handgrip strength. These findings suggest that gamified VR training may enhance multiple interrelated components leading to more integrated functional gains to mitigate sarcopenia-related decline and promote physical independence in the oldest-old population. This potential benefit of VR-based interventions is consistent with previous evidence that yields multidimensional functional improvements in older adults, including strength, balance and aerobic capacity, as well as cardiovascular performance [38,39,40,41,42,43,44,45]. Moreover, prior evidence links virtual environments with improved motor learning and cognitive–emotional outcomes in older adults [41,42,43]. Our earlier findings with the same intervention further confirm benefits for visuomotor coordination and attention [20]. On the other hand, it seems that without targeted intervention, the overall functionality of the elderly may remain more difficult to improve.
Physical function naturally declines owing to physiological changes associated with aging, such as sarcopenia. In the present study, participants in the VR group showed significant improvements in key physical performance outcomes, indicating that VR-based exercise may offer substantial benefits for the health and quality of life of older adults. Therefore, VR-based training may represent a valuable strategy for supporting functional performance and physical capacity in elderly at risk of sarcopenia. It is of particular importance in sustaining engagement among the oldest-old that, unlike conventional exercise, VR offers immersion, enjoyment, and rewards that enhance intrinsic motivation. Although VR is often associated with younger users [14], our results show that it can be effectively adapted for adults aged 80 years and older. High acceptance rates, despite concerns about digital exclusion and cognitive limitations, likely stemmed from the simple, rhythmic, and feedback-driven format, which encouraged engagement and adherence.

5. Limitations

Although muscle-mass-related anthropometric parameters were assessed before and after the intervention, no statistically significant changes were observed. This is most likely attributable to the short duration of the intervention, which was insufficient to induce measurable structural muscle adaptations. Consequently, the present findings should be interpreted as short-term functional responses rather than evidence of changes in muscle mass or sarcopenia as a clinical condition. Moreover, handgrip strength was assessed using a digital dynamometer other than the Jamar device, which may limit direct comparability with studies using gold-standard instrumentation; however, internal consistency was ensured by using the same device and protocol throughout this study. Although the results suggest a beneficial impact of VR-based intervention on selected physical performance parameters in the oldest-old population, this study was designed as a pilot study feasibility-oriented investigation and is therefore subject to several methodological limitations. Most notably, no a priori sample size calculation was performed, and the relatively small sample size (n = 38) determined by the available population of the long-term care facility limits statistical power and restricts the generalizability of the findings to broader elderly populations. Consequently, the results should be interpreted with caution, particularly with regard to the detection of smaller effects. Despite these limitations, this study demonstrates the practical feasibility of implementing VR-based exercise interventions in institutionalized very old adults and provides preliminary data that may inform future sample size and power calculations in larger, confirmatory trials. Furthermore, all participants were recruited from a single long-term care facility, which narrows the social and environmental context of this study and may further limit external validity.
Daily physical activity levels and dietary intake were not objectively quantified using questionnaires, dietary records, or wearable devices. Although daily routines and meal provision were standardized at the institutional level, unmeasured individual variability in activity and nutrition may have influenced the observed outcomes. The trial was registered retrospectively, reflecting its exploratory and feasibility-oriented design. The intervention lasted only four weeks and all outcome measures were collected immediately post-intervention. Post-intervention assessments were conducted shortly after the final training session, which may have been influenced by acute exercise effects, including transient fatigue, potentially affecting performance outcomes. No follow-up was conducted to assess the long-term sustainability of the observed effects, such as maintenance of muscle strength gains or functional performance improvements. The absence of longitudinal data prevents the determination of whether the benefits are transient or can be sustained in daily life. Minor baseline imbalances between groups were observed but were not statistically adjusted for due to the small sample size and exploratory nature of the analysis. In future trials, a larger sample with stratified randomization and covariate adjustment is recommended to enhance statistical validity. It is also worth considering the integration of dietary components into future activation programs, particularly nutritional strategies based on low-carbohydrate or anti-inflammatory diets, which, according to the literature, may support sarcopenia management [44,45]. A comprehensive approach combining exercise, nutrition and modern technologies could offer a more effective strategy to delay age-related functional decline and maintain independence in older adults.

6. Conclusions

This pilot study demonstrated that a four-week gamified virtual reality training using the commercial game Beat Saber can improve key indicators of physical function among the oldest-old population. Significant gains were observed in both upper- and lower-limb strength, particularly in arm curl and chair stand performance. Notably, handgrip strength was preserved in the VR group but declined in the control group, highlighting the potential of such interventions to slow functional deterioration in advanced age.
The results support the feasibility and acceptability of VR-based exercise programs in institutionalized adults aged 80 years and older. The use of immersive and engaging environments may facilitate adherence and participation, addressing common barriers to physical activity in this population. Nevertheless, the findings should be interpreted in light of the pilot and feasibility-oriented design of this study, the limited sample size, and the absence of long-term follow-up.
Future studies should involve larger samples, a longer intervention period, follow-up assessments and integrative approaches combining VR-based physical training with targeted dietary strategies (e.g., anti-inflammatory or protein-rich diets). Such a multifaceted model may represent a promising pathway toward preserving autonomy and quality of life in aging populations by improving functional performance indicators associated with sarcopenia risk.

Author Contributions

Conceptualization: Ż.G.; Methodology: Ż.G.; Validation: Ż.G. and E.M.; Formal analysis: Ż.G., E.M. and A.K.; Investigation: Ż.G. and J.J.; Resources: Ż.G.; Data Curation: Ż.G. and J.M.; Writing—Original Draft: Ż.G. and E.M.; Writing—Review and Editing: Ż.G., E.M., A.K., J.M. and J.J.; Visualization: Ż.G. and E.M.; Supervision: Ż.G. and E.M.; Project Administration: Ż.G.; Funding Acquisition: Ż.G. and E.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by Opole University of Technology as part of the DELTA project No. 255/24.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and was approved by Bioethics Committee of the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla street 12, 53-114 Wrocław, PL (Opinion Bioethics Committee #KB-10/2024, 2 July 2024).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study. Written informed consent has been obtained from the patient(s) to publish this paper, if applicable.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to the protection of research participant privacy.

Acknowledgments

The authors would like to express their sincere gratitude to Agata Mrózek, Director of the Nursing Home Pogodna Jesień in Opole, for her valuable support in the organization of this study. We also thank the medical staff of the facility, in particular, physician Anna Piskorowska-Pliś and Agata Kurdziel, for their professional care. Finally, we gratefully acknowledge participation in this study by all our volunteers. During the preparation of this manuscript, the authors used an AI-based tool (ChatGPT/DALL·E, 2025) solely to generate a clearer and more readable graphical visualization based on original research photographs. No new visual content, identities, or elements beyond stylistic enhancement were created by the AI system. All original materials were produced within this study. The authors have reviewed and edited the AI-assisted output and take full responsibility for the final content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Appendix A

Table A1. Cut-off points for physical performance tests indicating sarcopenia risk (n; %) #.
Table A1. Cut-off points for physical performance tests indicating sarcopenia risk (n; %) #.
TestCut-Off PointReference
Handgrip strength<27 kg (men), <16 kg (women)European Working Group on Sarcopenia in Older People 2 (EWGSOP2, 2019) [4]
Arm curl test<11.5 repetitions (both men and women)Lima, A.B., Baptista, F., Henriques-Neto, D., Pinto, A.A., & Gouveia, E.R. (2023) [22]
30-s chair stand test<15 repetitions (women), <17 repetitions (men)Sawada, S. et al. (2021) [23]
8-foot up-and-go test>10.85 sMartinez, B.P. et al. (2015) [24]
2-min step-in-place test<60 stepsPoncumnhak, P. et al. (2023) [25]
Description of Sarcopenia Risk (n; %) #: The risk of sarcopenia among participants was determined based on their performance in selected functional fitness tests, applying established cut-off points from validated sources. According to the European Working Group on Sarcopenia in Older People 2 [4], low muscle strength was defined as handgrip strength <27 kg for men and <16 kg for women. Upper-limb muscular endurance was assessed using the arm curl test, with values below 11.5 repetitions considered indicative of reduced performance [22]. Lower-body strength was evaluated using the 30-s chair stand test, where fewer than 15 repetitions in women and 17 in men indicated reduced lower-limb function [23]. Functional mobility was assessed by the 8-foot up-and-go test, with times exceeding 10.85 s interpreted as reduced performance [24]. Aerobic endurance was measured using the 2-min step-in-place test, where the results below 60 steps indicated diminished functional capacity [25]. Participants who met one or more of these criteria were categorized as being at risk of sarcopenia. This multidimensional approach, integrating measures of muscle strength, endurance, mobility, and aerobic performance, provides a comprehensive assessment of age-related functional decline and identifies individuals potentially vulnerable to sarcopenia-related impairment.

References

  1. Burns, E.R.; Stevens, J.A.; Lee, R. The direct costs of fatal and non-fatal falls among older adults—United States. J. Saf. Res. 2016, 58, 99–103. [Google Scholar] [CrossRef] [PubMed]
  2. Hosoi, T.; Yakabe, M.; Hashimoto, S.; Akishita, M.; Ogawa, S. The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reprod. Med. Biol. 2024, 23, e12569. [Google Scholar] [CrossRef] [PubMed]
  3. Kinoshita, K.; Satake, S.; Matsui, Y.; Arai, H. Association between sarcopenia and fall risk according to the muscle mass adjustment method in Japanese older outpatients. J. Nutr. Health Aging 2021, 25, 762–766. [Google Scholar] [CrossRef] [PubMed]
  4. Cruz-Jentoft, A.J.; Bahat, G.; Bauer, J.; Boirie, Y.; Bruyère, O.; Cederholm, T.; Cooper, C.; Landi, F.; Rolland, Y.; Sayer, A.A.; et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019, 48, 16–31, Erratum in Age Ageing 2019, 48, 601. https://doi.org/10.1093/ageing/afz046. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  5. Hashimoto, S.; Hosoi, T.; Yakabe, M.; Yunoki, M.; Matsumoto, S.; Kase, Y.; Miyawaki, M.; Ishii, M.; Ogawa, S. Preventative approaches to falls and frailty. Osteoporos. Sarcopenia 2025, 11, 50–53. [Google Scholar] [CrossRef]
  6. Dent, J.E.; Morley, A.J.; Cruz-Jentoft, H.; Arai, S.B.; Kritchevsky, J.; Guralnik, J.M.; Bauer, M.; Pahor, B.C.; Clark, M.; Cesari, J.; et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management. J. Nutr. Health Aging 2018, 22, 1148–1161. [Google Scholar] [CrossRef]
  7. Ethgen, O.; Beaudart, C.; Buckinx, F.; Bruyère, O.; Reginster, J.Y. The Future Prevalence of Sarcopenia in Europe: A Claim for Public Health Action. Calcif. Tissue Int. 2017, 100, 229–234. [Google Scholar] [CrossRef]
  8. von Haehling, S.; Morley, J.E.; Anker, S.D. An overview of sarcopenia: Facts and numbers on prevalence and clinical impact. J. Cachexia Sarcopenia Muscle 2010, 1, 129–133. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  9. Zhang, F.; Li, W. Vitamin D and Sarcopenia in the Senior People: A Review of Mechanisms and Comprehensive Prevention and Treatment Strategies. Ther. Clin. Risk Manag. 2024, 20, 577–595. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  10. Kim, G.; Kim, J.H. Impact of skeletal muscle mass on metabolic health. Endocrinol. Metab. 2020, 35, 1–6. [Google Scholar] [CrossRef]
  11. Kim, H.; Kim, J.; Lee, C.; Kim, S. Nutrition and exercise for sarcopenia treatment. Osteoporos. Sarcopenia 2025, 11, 54–64. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  12. Novak, P.; Lhotska, L. Enhancing cognitive and motor skills through personalized digital games. In Joint 20th Nordic-Baltic Conference on Biomedical Engineering & 24th Polish Conference on Biocybernetics and Biomedical Engineering (NBC PCBBE 2025); Ladyzynski, P., Pijanowska, D.G., Liebert, A., Eds.; Springer: Berlin/Heidelberg, Germany, 2025; Volume 131. [Google Scholar] [CrossRef]
  13. Selles, W.; Santos, E.; Romero, B.; Lunardi, A. Effectiveness of gamified exercise programs on the level of physical activity in adults with chronic diseases: A scoping review. Braz. J. Phys. Ther. 2024, 28, 101024. [Google Scholar] [CrossRef]
  14. Mariano, J.; Marques, S.; Ramos, M.R.; Gerardo, F.; da Cunha, C.L.; Girenko, A.; De Vries, H. Too old for technology? Stereotype threat and technology use by older adults. Behav. Inf. Technol. 2022, 41, 1503–1514. [Google Scholar] [CrossRef]
  15. Gutiérrez-Pérez, B.-M.; Martín-García, A.-V.; Murciano-Hueso, A. Use of serious games with older adults: Systematic literature review. Humanit. Soc. Sci. Commun. 2023, 10, 939. [Google Scholar] [CrossRef]
  16. Kukkohovi, S.; Siira, H.; Arolaakso, S.; Miettunen, J.; Elo, S. The effectiveness of digital gaming on the functioning and activity of older people living in long-term care facilities: A systematic review and meta-analysis. Aging Clin. Exp. Res. 2023, 35, 1595–1608. [Google Scholar] [CrossRef]
  17. Chen, J.; Yan, S.; Yin, H.; Lin, D.; Mei, Z.; Ding, Z.; Wang, M.; Bai, Y.; Xu, G. Virtual reality technology improves the gait and balance function of the elderly: A meta-analysis of randomized controlled trials. Arch. Med. Sci. 2024, 20, 1918–1929. [Google Scholar] [CrossRef]
  18. Zheng, L.; Li, X.; Xu, Y.; Yang, Y.; Wan, X.; Ma, X.; Yao, G.; Li, G. Effects of Virtual Reality-Based Activities of Daily Living Rehabilitation Training in Older Adults With Cognitive Frailty and Activities of Daily Living Impairments: A Randomized Controlled Trial. J. Am. Med. Dir. Assoc. 2025, 26, 105397. [Google Scholar] [CrossRef] [PubMed]
  19. Szpak, A.; Michalski, S.C.; Loetscher, T. Exergaming With Beat Saber: An Investigation of Virtual Reality Aftereffects. J. Med. Internet Res. 2020, 22, e19840. [Google Scholar] [CrossRef] [PubMed]
  20. Grzywacz, Ż.; Jaśniewicz, J.; Koziarska, A.; Borzucka, D.; Majorczyk, E. Virtual Reality Gaming and Its Impact and Effectiveness in Improving Eye–Hand Coordination and Attention Concentration in the Oldest-Old Population. J. Clin. Med. 2025, 14, 4651. [Google Scholar] [CrossRef] [PubMed]
  21. Rikli, R.E.; Jones, C.J. Senior Fitness Test Manual, 2nd ed.; Human Kinetics: Champaign, IL, USA, 2013. [Google Scholar]
  22. de Lima, A.B.; Baptista, F.; Henrinques-Neto, D.; Pinto, A.d.A.; Gouveia, E.R. Symptoms of Sarcopenia and Physical Fitness through the Senior Fitness Test. Int. J. Environ. Res. Public Health 2023, 20, 2711. [Google Scholar] [CrossRef]
  23. Sawada, S.; Ozaki, H.; Natsume, T.; Deng, P.; Yoshihara, T.; Nakagata, T.; Osawa, T.; Ishihara, Y.; Kitada, T.; Kimura, K.; et al. The 30-s chair stand test can be a useful tool for screening sarcopenia in elderly Japanese participants. BMC Musculoskelet. Disord. 2021, 22, 639. [Google Scholar] [CrossRef] [PubMed]
  24. Martinez, B.P.; Gomes, I.B.; Oliveira, C.S.; Silva Júnior, W.M.; Carvalho, V.O.; Maldonado, I.R.D. Accuracy of the Timed Up and Go test for predicting sarcopenia in elderly hospitalized patients. Clinics 2015, 70, 369–372. [Google Scholar] [CrossRef] [PubMed]
  25. Poncumhak, P.; Amput, P.; Sangkarit, N.; Promsrisuk, T.; Srithawong, A. Predictive ability of the 2-minute step test for functional fitness in older individuals with hypertension. Ann. Geriatr. Med. Res. 2023, 27, 228–234, Correction in Ann. Geriatr. Med. Res. 2024, 28, 491. [Google Scholar] [CrossRef] [PubMed]
  26. McGrath, R.; Vincent, B.M.; Jurivich, D.A.; Hackney, K.J.; Tomkinson, G.R.; Dahl, L.J.; Clark, B.C. Handgrip Strength Asymmetry and Weakness Together Are Associated With Functional Disability in Aging Americans. J. Gerontol. A Biol. Sci. Med. Sci. 2021, 76, 291–296. [Google Scholar] [CrossRef] [PubMed]
  27. Bohannon, R.W. Grip Strength: An Indispensable Biomarker For Older Adults. Clin. Interv. Aging 2019, 14, 1681–1691. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  28. Govindasamy, K.; Rao, C.R.; Chandrasekaran, B.; Parpa, K.; Granacher, U. Effects of Resistance Training on Sarcopenia Risk Among Healthy Older Adults: A Scoping Review of Physiological Mechanisms. Life 2025, 15, 688. [Google Scholar] [CrossRef]
  29. Kim, D.; Morikawa, S.; Miyawaki, M.; Nakagawa, T.; Ogawa, S.; Kase, Y. Sarcopenia prevention in older adults: Effectiveness and limitations of non-pharmacological interventions. Osteoporos. Sarcopenia 2025, 11, 65–72. [Google Scholar] [CrossRef]
  30. Talar, K.; Hernández–Belmonte, A.; Vetrovsky, T.; Steffl, M.; Kałamacka, E.; Courel-Ibáñez, J. Benefits of resistance training in early and late stages of frailty and sarcopenia: A systematic review and meta-analysis of randomized controlled studies. J. Clin. Med. 2021, 10, 1630. [Google Scholar] [CrossRef]
  31. Bao, W.; Sun, Y.; Zhang, T.; Zou, L.; Wu, X.; Wang, D.; Chen, Z. Exercise Programs for Muscle Mass, Muscle Strength and Physical Performance in Older Adults with Sarcopenia: A Systematic Review and Meta-Analysis. Aging Dis. 2020, 11, 863–873. [Google Scholar] [CrossRef]
  32. Chen, N.; He, X.; Feng, Y.; Ainsworth, B.E.; Liu, Y. Effects of resistance training in healthy older people with sarcopenia: A systematic review and meta-analysis of randomized controlled trials. Eur. Rev. Aging Phys. Act. 2021, 18, 23. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  33. Song, Z.; Pan, T.; Tong, X.; Yang, Y.; Zhang, Z. The effects of nutritional supplementation on older sarcopenic individuals who engage in resistance training: A meta-analysis. Front. Nutr. 2023, 10, 1109789. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  34. Sherrington, C.; Fairhall, N.J.; Wallbank, G.K.; Tiedemann, A.; Michaleff, Z.A.; Howard, K.; Clemson, L.; Hopewell, S.; Lamb, S.E. Exercise for preventing falls in older people living in the community. Cochrane Database Syst. Rev. 2019, 1, CD012424. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  35. Cadore, E.L.; Izquierdo, M. How to simultaneously optimize muscle strength, power, functional capacity, and cardiovascular gains in the elderly: An update. Age 2013, 35, 2329–2344. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  36. da Silva Rodrigues, G.; da Silva Sobrinho, A.C.; Costa, G.P.; da Silva, L.S.L.; de Lima, J.G.R.; da Silva Gonçalves, L.; Finzeto, L.C.; Bueno Júnior, C.R. Benefits of physical exercise through multivariate analysis in sedentary adults and elderly: An analysis of physical fitness, health and anthropometrics. Exp. Gerontol. 2025, 200, 112669. [Google Scholar] [CrossRef] [PubMed]
  37. Pan, P.J.; Hsu, N.W.; Lee, M.J.; Lin, Y.Y.; Tsai, C.C.; Lin, W.S. Physical fitness and its correlation with handgrip strength in active community-dwelling older adults. Sci. Rep. 2022, 12, 17227. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  38. Molina, K.I.; Ricci, N.A.; de Moraes, S.A.; Perracini, M.R. Virtual reality using games for improving physical functioning in older adults: A systematic review. J. Neuroeng. Rehabil. 2014, 11, 156. [Google Scholar] [CrossRef]
  39. Parmak, D.; Angın, E.; Iyigun, G. Effects of Immersive Virtual Reality on Physical Function, Fall-Related Outcomes, Fatigue, and Quality of Life in Older Adults: A Randomized Controlled Trial. Healthcare 2025, 13, 1800. [Google Scholar] [CrossRef]
  40. Chitjamnogchai, C.; Yuenyongchaiwat, K.; Sermsinsaithong, N.; Tavonudomgit, W.; Mahawong, L.; Buranapuntalug, S.; Thanawattano, C. Home-Based Virtual Reality Exercise and Resistance Training for Enhanced Cardiorespiratory Fitness in Community-Dwelling Older People with Sarcopenia: A Randomized, Double-Blind Controlled Trial. Life 2025, 15, 986. [Google Scholar] [CrossRef] [PubMed]
  41. Song, X.; Ali, N.M.; Mhd Salim, M.H.; Rezaldi, M.Y. A Literature Review of Virtual Reality Exergames for Older Adults: Enhancing Physical, Cognitive, and Social Health. Appl. Sci. 2025, 15, 351. [Google Scholar] [CrossRef]
  42. Tokgöz, P.; Stampa, S.; Wähnert, D.; Vordemvenne, T.; Dockweiler, C. Virtual Reality in the Rehabilitation of Patients with Injuries and Diseases of Upper Extremities. Healthcare 2022, 10, 1124. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  43. Chan, L.P.P.; Cheng, Y.; Ng, J.Y.H.; Zheng, Z.; Cheing, G.L.Y. A Review of Virtual Reality Technology in Exercise Training for Older Adults. J. Endocrinol. Thyroid Res. 2022, 6, 555694. [Google Scholar] [CrossRef]
  44. Li, Y.; Huang, Y.; Yan, J.; Li, T.; Wang, Y. Anti-inflammatory diet and low muscle mass among older adults: A cohort study based on clhls. Geriatr. Nurs. 2025, 64, 103378. [Google Scholar] [CrossRef] [PubMed]
  45. Zhao, L.; Wang, X.; Zhang, Y.; Jiang, Z. Association between the dietary inflammatory index and sarcopenia: A systematic review and meta-analysis. Front. Nutr. 2023, 10, 1100918. [Google Scholar] [CrossRef]
Figure 1. CONSORT flow diagram showing participant enrollment, randomization, allocation, follow-up, and analysis (n = 39 randomized).
Figure 1. CONSORT flow diagram showing participant enrollment, randomization, allocation, follow-up, and analysis (n = 39 randomized).
Jcm 15 00621 g001
Figure 2. A composite visualization of the virtual reality (VR) training setup used in this study, illustrating the headset, controllers, and the experimental environment of the Beat Saber game. Source: The composite image was created by the authors using their own photographs with a screenshot from Beat Saber (© Beat Games/Meta Platforms Inc., Menlo Park, CA, USA), integrated and stylized with AI-assisted tools (ChatGPT/DALL·E, OpenAI, 2025).
Figure 2. A composite visualization of the virtual reality (VR) training setup used in this study, illustrating the headset, controllers, and the experimental environment of the Beat Saber game. Source: The composite image was created by the authors using their own photographs with a screenshot from Beat Saber (© Beat Games/Meta Platforms Inc., Menlo Park, CA, USA), integrated and stylized with AI-assisted tools (ChatGPT/DALL·E, OpenAI, 2025).
Jcm 15 00621 g002
Figure 3. Spearman’s rank correlation matrix between sarcopenia-related functional indicators before and after the intervention in the VR group (A) and the control group (B). Colors represent the strength and direction of correlations, with blue indicating positive correlations and red indicating negative correlations; color intensity reflects the magnitude of the correlation coefficient. The red boxes highlight statistically significant correlations discussed in detail in the text.
Figure 3. Spearman’s rank correlation matrix between sarcopenia-related functional indicators before and after the intervention in the VR group (A) and the control group (B). Colors represent the strength and direction of correlations, with blue indicating positive correlations and red indicating negative correlations; color intensity reflects the magnitude of the correlation coefficient. The red boxes highlight statistically significant correlations discussed in detail in the text.
Jcm 15 00621 g003
Table 1. Characteristics of study groups.
Table 1. Characteristics of study groups.
Groups (n)Age
(Years)
Sex
(Women/Men)
Weight
(kg)
Height
(cm)
BMI
(kg/m2)
All cases (38)87.2 (±6.3) 29/968 (±14.5) 157.4 (±10.2)27.7 (±6.4)
VR group (19)88.0 (±6.4)14/570.8 (±8.3) 161.4 (±8.3)27.2 (±6.6)
Control group (19)86.4 (±6.3)15/465.1(±12.2)153.5 (±10.6)28.2 (±6.4)
Table 2. Intergroup and intragroup differences in measures related to sarcopenia risk.
Table 2. Intergroup and intragroup differences in measures related to sarcopenia risk.
Parameters Related to Sarcopenia RiskGroups
VR Group
T0 (Before)
VR Group
T1 (After)
Control Group
T0 (Before)
Control Group
T1 (After)
Handgrip strength
(kg)
Mean (SD)17.9 (5.9)18.7 (5.6)17.8 (4.36)17.2 (4.9)
Median (Q1-Q3)16.8 (15.2–18.5)17.9 (15.2–20.1)16.4 (14.9–20.9)15.2 (13.8–20.7)
Difference T0 vs. T10.8 ↑0.6 ↓
Sarcopenia risk (n;%) #8 (42.1)7 (36.8)14 (73.7)13 (68.4)
Arm curl
test (n)
Mean (SD)14.2 (5.6)18.5 (5.0)10.3 (4.4)10.8 (3.8)
Median (Q1–Q3)14.0 (11–19.5)18.0 (14.5–22.5)9.0 (7.5–13)11.0 (8–12.5)
Difference T0 vs. T14.3 ↑0.5 ↑
Sarcopenia risk (n;%) #6 (31.6)1 (5.3)13 (68.4)10 (52.6)
30-s chair stand (n)Mean (SD)9.32 (4.0)12.5 (5.5)4.16 (3.7)4.11 (4.3)
Median (Q1–Q3)9.0 (8.0–12.0)14.0 (9.5–16.5)3.0 (2.0–5.5)3.0 (0.0–7.0)
Difference T0 vs. T15.0 ↑0.0 =
Sarcopenia risk (n;%) #19 (100.0)14 (73.7)19 (100.0)19 (100.0)
8-foot up-and-go (n)Mean (SD)18.7 (16.2)15.9 (10.7)15.3 (16.2)14.9 (16.5)
Median (Q1–Q3)15.5 (9.02–17.9)12.5 (9.43–19.1)16.2 (0.0–26.6)16.5 (0.0–26.9)
Difference T0 vs. T12.8 ↓0.4 ↓
Sarcopenia risk (n;%) #5 (26.3)6 (31.6)9 (47.4)7 (36.8)
2-min step-in-place (n)Mean (SD)74.7 (33.2)85.8 (30.7)42.2 (41.5)53.2 (48.8)
Median (Q1–Q3)75.0 (50.0–97.5)94.0 (73.0–106.0)41.5 (0.0–83.5)48.4 (0.0–91.0)
Difference T0 vs. T111.1 ↑11.0 ↑
Sarcopenia risk (n;%) #8 (42.1)2 (10.5)12 (63.2)10 (52.6)
Statistical Analyses—Linear Mixed Model
Time/GroupEMM (95%CI)EffectF1,36p Value
Handgrip strength
[kg]
T0 VR17.9 (15.6–20.3)Time0.1000.754
T1 VR18.7 (16.4–21.0)Group0.2190.643
T0 control17.8 (15.5–20.2)Time × group4.6840.037
T1 control17.2 (14.9–19.6)
Arm curl
test (n)
T0 VR14.2 (12.0–16.3)Time10.1610.003
T1 VR18.5 (16.4–20.7)Group18.701<0.001
T0 control10.3 (8.2–12.4)Time × group6.5740.015
T1 control10.8 (8.7–12.9)
30-s chair stand (n)T0 VR9.3 (7.3–11.3)Time21.211<0.001
T1 VR12.5 (10.5–14.5)Group23.641<0.001
T0 control4.2 (2.2–6.1)Time × group22.674<0.001
T1 control4.1 (2.1–6.1)
8-foot up-and-go (n)T0 VR18.7 (11.9–25.4)Time2.0040.165
T1 VR15.9 (9.1–22.6)Group0.2010.657
T0 control15.3 (8.6–22.1)Time × group1.1030.301
T1 control14.9 (8.1–21.7)
2-min step-in-place (n)T0 VR74.7 (57.1–92.2)Time0.1000.754
T1 VR85.7 (68.2–103.4)Group0.2190.643
T0 control42.2 (24.6–59.7)Time × group4.6840.037
T1 control53.2 (35.6–70.7)
Sarcopenia risk (n; %): # represents the proportion of participants whose performance in a given functional test was below the established cut-off values for muscle strength, endurance, mobility, or aerobic capacity.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Grzywacz, Ż.; Jaśniewicz, J.; Koziarska, A.; Macierzyńska, J.; Majorczyk, E. The Effects of Gamified Virtual Reality on Muscle Strength and Physical Function in the Oldest Old—A Pilot Study on Sarcopenia-Related Functional Outcomes. J. Clin. Med. 2026, 15, 621. https://doi.org/10.3390/jcm15020621

AMA Style

Grzywacz Ż, Jaśniewicz J, Koziarska A, Macierzyńska J, Majorczyk E. The Effects of Gamified Virtual Reality on Muscle Strength and Physical Function in the Oldest Old—A Pilot Study on Sarcopenia-Related Functional Outcomes. Journal of Clinical Medicine. 2026; 15(2):621. https://doi.org/10.3390/jcm15020621

Chicago/Turabian Style

Grzywacz, Żaneta, Justyna Jaśniewicz, Anna Koziarska, Joanna Macierzyńska, and Edyta Majorczyk. 2026. "The Effects of Gamified Virtual Reality on Muscle Strength and Physical Function in the Oldest Old—A Pilot Study on Sarcopenia-Related Functional Outcomes" Journal of Clinical Medicine 15, no. 2: 621. https://doi.org/10.3390/jcm15020621

APA Style

Grzywacz, Ż., Jaśniewicz, J., Koziarska, A., Macierzyńska, J., & Majorczyk, E. (2026). The Effects of Gamified Virtual Reality on Muscle Strength and Physical Function in the Oldest Old—A Pilot Study on Sarcopenia-Related Functional Outcomes. Journal of Clinical Medicine, 15(2), 621. https://doi.org/10.3390/jcm15020621

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop